Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Yakovlev reported for 9 months of 2024 by RAS

10/23/24 IRKT

Gazprom Neft will develop an electric charging network under the Rozetka brand

10/23/24 SIBN

Board of Directors of Polyus recommended dividends

10/23/24 PLZL

Red October reported for 9 months of 2024 by RAS

10/23/24 KROT

Lambumiz started accepting applications for participation in the IPO

10/23/24 LMBZ

Pharmacy Chain 36.6 bought back 37.3 million of its shares

10/22/24 APTK

Moscow Exchange launched trading in Nornickel's platinum and palladium

10/22/24 GMKN

T-Bank wants to become an organizer of share incentive programs

10/22/24 T

TMK reported for 9 months of 2024 by RAS

10/22/24 TRMK

Softline has entered the market of Uzbekistan

10/22/24 SOFL